Company & Sponsor Intelligence

UMC Utrecht

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials7

Recruiting3

Completed0

Countries1

Therapeutic footprint

adhdautismepilepsyother_neurologyother_psychiatry

Indexed studies

NCT00189189Prevention of Oppositional Defiant and Conduct Disorders in Preschool Children
other_psychiatry · NetherlandsNA

NCT00143832Genetic Risk for Attention Deficit Hyperactivity Disorder Expressed in Brain Functioning
adhd · NetherlandsUNKNOWN

NCT04158531REC2Stim as a Treatment for Refractory Epilepsy in the Primary Sensorimotor Cortex.
epilepsy · NetherlandsNA

NCT07668856Cannabidiol as add-on Therapy for Children With Refractory Epilepsy (CBD-uN1que), a High-quality Individualized Approach: a Series of N-of-1 Trials
epilepsy · NetherlandsPHASE3

NCT07111975ANEURYSM@RISK: Automatic Intracranial Aneurysm Quantification and Feature Learning Modelling to Optimize Intracranial Aneurysm Rupture Prediction
other_neurology · NetherlandsACTIVE_NOT_RECRUITING

NCT00143767Magnetic Resonance Imaging of Brain Development in Attention Deficit Hyperactivity Disorder
adhd · NetherlandsUNKNOWN

NCT06925308Course of Face-to-face Interactions in Adults With Autism
autism · NetherlandsNA

Intelligence layer updated: 2026-10-14 06:11:28.884102+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →